Mechanisms in COPD: Differences from asthma

Chest

Volumn 117, Issue 2 SUPPL., 2000, Pages 10S-14S

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Antiprotease; Corticosteroids; Eosinophil; Macrophage; Matrix metalloprotinase; Neutrophil; Neutrophil elastase; Protease

Indexed keywords

ALPHA 1 ANTITRYPSIN; CHEMOKINE; CORTICOSTEROID; CYTOKINE; ENZYME; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE; PROTEINASE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EOSINOPHIL; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; MACROPHAGE; NEUTROPHIL; PRIORITY JOURNAL; REVIEW;

EID: 0033994635     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Barnes PJ. Pathophysiology of asthma. Br J Clin Pharmacol 1996; 42:3-10
2. Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998; 53:129-136
3. Saetta M, Di Stefano A, Maestrelli P, et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147:301-306
4. Saetta M, Di Stefano A, Turato G, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:822-826
5. Thompson PB, Daughton D, Robbins GA, et al. Intramural airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters. Am Rev Respir Dis 1989; 140:1527-1537
6. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-α induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-534
7. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma and normal subjects. Am J Respir Crit Care Med 1997; 155:449-453
8. Liu H, Lazarus SC, Caughey GH, et al. Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro. Am J Physiol 1999; 276:L28-L34
9. Turato G, Di Stefano A, Maestrelli P, et al. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med 1995; 152:1262-1267
10. Finkelstein R, Fraser RS, Ghezzo H, et al. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995; 152:1666-1672
11. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma; an update. Pharmacol Rev 1998; 50:515-596
12. Zakrzewski JT, Barnes NC, Costello JF, et al. Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease. Am Rev Respir Dis 1987; 136:779-782
13. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999; 54:825-857
14. Yamamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997; 112:505-510
15. Barnes PJ, Karin M. Nuclear factor-KB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-1071
16. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156:341-357
17. 2a-111, an index of oxidant stress. Am J Respir Crit Care Med 1998; 158:1709-1714
18. Shapiro SD. Elastolytic metalloproteinases produced by human mononuclear phagocytes: potential roles in destructive lung disease. Am J Respir Crit Care Med 1994; 150(Suppl): S160-S164
19. Finlay GA, Russell KJ, McMahon KJ, et al. Elevated levels of matrix metalloproteinases in bronchoalvoelar lavage fluid of emphysematous patients. Thorax 1997; 52:502-506
20. Ohnishi K, Takagi M, Kurokawa Y, et al. Matrix metalloproteinase mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998; 78:1077-1087
21. Finlay GA, O'Driscoll LR, Russell KJ, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997; 156:240-247
22. Shapiro SG, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993; 268:23824-23829
23. Hautamaki RD, Kobayashi DK, Senior RM, et al. Requirement for macrophage metalloelastase for cigarette smoke-induced emphysema in mice. Science 1997; 277:2002-2004
24. Vignole AM, Riccobono L, Mirabella A, et al. Sputum metalloprotinase-9/tissue inhibitor of metalloprotinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998; 158:1945-1950
25. Barnes PJ. Mechanism of action of glucocorticoids in asthma. Am J Respir Crit Care Med 1996; 154(Suppl):S21-S27
26. Keatings VM, Jatakanon A, Worsdell YM, et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155:542-548
27. Culpitt SV, Nightingale JA, Barnes PJ. Effect of fluticasone propionate on induced sputum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with COPD. Am J Respir Crit Care Med 1999; 160:1635-1639
28. Meagher LC, Cousin JM, Seckl JR, et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granuloctyes. J Immunol 1996; 156:4422-4428
29. Barnes PJ. New therapies for chronic obstructive pulmonary disease. Thorax 1998; 53:137-147
30. Barnes PJ. Chronic obstructive pulmonary disease: new opportunities for drug development. Trends Pharmacol Sci 1998; 19:415-423